Immunohistochemical expression of MMP-2, MMP-9, and TIMP-2 in neuroblastoma: Association with tumor progression and clinical outcome
- 1 August 1998
- journal article
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 33 (8) , 1272-1278
- https://doi.org/10.1016/s0022-3468(98)90167-1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Colocalisation of matrix metalloproteinase-9-mRNA and protein in human colorectal cancer stromal cellsBritish Journal of Cancer, 1996
- Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinomaBritish Journal of Cancer, 1996
- 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancerInternational Journal of Cancer, 1996
- gelatinase A/TIMP‐2 imbalance in lymph‐node‐positive breast carcinomas, as measured by RT‐PCRInternational Journal of Cancer, 1995
- Enhanced expression of tissue inhibitor of metalloproteinase‐2 (TIMP‐2) in the stroma of breast carcinomas correlates with tumor recurrenceInternational Journal of Cancer, 1994
- Expression of Type IV Collagen and Its Degrading Enzymes in Squamous Cell Carcinoma of LungJapanese Journal of Cancer Research, 1994
- Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumorsJournal of Neurosurgery, 1994
- Immunohistochemical localization of matrix metallloproteinase 2 and its specific inhibitor timp‐2 in neoplastic tissues with monclonal antibodiesInternational Journal of Cancer, 1994
- The matrix‐degrading metalloproteinasesBioEssays, 1992
- Tissue Inhibitor of Metalloproteinase (TIMP-2)Journal of Biological Chemistry, 1989